MLB
notebook: Astros’ Martes faces 80-game suspension
Send a link to a friend
[March 13, 2019]
Injured Houston Astros
right-handed pitcher Francis Martes has received an 80-game
suspension after testing positive for Clomiphene, a
performance-enhancing substance, Major League Baseball announced
Tuesday.
The Astros said in a statement Tuesday that they "hope that Francis
can learn from this experience and that he returns to have a
successful career."
Clomiphene is an anti-estrogen substance used in fertility
treatments and employed by men to accelerate testosterone
production. It is taken along with steroids to inhibit estrogen
problems. It is not FDA-approved for use by men, according to the
USDA, and has been placed on the list of banned substances.
Martes underwent Tommy John surgery on the ulnar collateral ligament
in his right elbow last Aug. 15, and was not scheduled to return
until the second half of the season, at the earliest. His suspension
will begin at the start of the 2019 regular season.
--Three-time Cy Young Award winner Max Scherzer will be the
Washington Nationals' Opening Day starter.
Manager Dave Martinez feigned surprise announcing the move, saying,
"I'm going to go out on a limb today and tell you that Max will be
our Opening Day starter."
[to top of second column] |
It will be Scherzer's fourth Opening Day nod in five seasons with
the team, and it will pit him against last year's Cy Young Award
winner, Jacob deGrom of the New York Mets, on March 28 in D.C.
Scherzer finished second to deGrom in Cy Young balloting last year.
--New York Mets outfielder Tim Tebow was assigned to minor league
camp.
Tebow joked in an interview with SNY that he would stay in touch
with the big-leaguers, saying, "It's only, like, three minutes away.
We have cell phones, too. I'll stay in touch with these guys."
Tebow, who had four hits and one RBI in 15 at-bats in the Grapefruit
League, is expected to start the 2019 season at Triple-A Syracuse.
--Field Level Media
[© 2019 Thomson Reuters. All rights
reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |